Results 181 to 190 of about 186,664 (282)

Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 1241. [PDF]

Int J Mol Sci
Jaksic Karisik M, Lazarevic M, Mitic D, Ajtic OM, Damante G, Milasin J.   +5 more
europepmc   +1 more source

CD44 Antigen [PDF]

, 2020
openaire   +1 more source

Pancancer Fine‐Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma

Advanced Science, EarlyView.
This study identifies mutation‐intolerant genes (MIGs), which are mutationally constrained in tumors despite normal‐tissue variability. Using miDriver, the authors pinpoint MIGs essential for tumor‐intrinsic fitness and immune evasion. Focusing on CHEK1, they show it drives tumor fitness and sculpts an immunosuppressive niche via the MIF–CD74 axis ...
Tao Wang, Hongyu Zhao, Xiaojie Sun, Yuqi Ding, Zhipeng Zhu, Xiaotong Yu, Rongyi Zhu, Dan Wang, Kailong Li, Yang Liu, Li‐Bin Wang, Xiaolu Zhao, Baojun Suo, Hongsen Bi, Peipei Zhang, Tong Liu, Fengbiao Mao   +16 more
wiley   +1 more source

The protective role of CD44 and microRNA-146a in tendinopathy. [PDF]

Bone Joint Res
Hsu CC, Chen SY, Ko PY, Jou IM, Yang HW, Chuang WJ, Wu PT.   +6 more
europepmc   +1 more source

Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD) [PDF]

Journal of Biological Chemistry, 2012
Karl E. Miletti-González, Kyle Murphy, Muthu N. Kumaran, Abhilash K. Ravindranath, Roman P. Wernyj, Swayamjot Kaur, Gregory D. Miles, Elaine Lim, Rigel Chan, Marina Chekmareva, Debra S. Heller, David Foran, Wenjin Chen, Michael Reiss, Elisa V. Bandera, Kathleen Scotto, Lorna Rodríguez-Rodríguez   +16 more
openaire   +1 more source

Mapping CSC‐Mediated Ovarian Cancer Chemoresistance via CXCR4‐PET to Guide Precision Cisplatin Re‐Sensitization Therapy

Advanced Science, EarlyView.
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng, Simei Zhao, Zheng Wei, Wenwen Wang, Feiquan Ying, Lin Huang, Mengna Zhu, Mengqing Chen, Qiang Yang, Si Sun, Dawei Jiang, Lingling Gao, Jing Cai   +12 more
wiley   +1 more source

Exercise as Precision Medicine: Targeting HER2/CD44-Driven Therapy Resistance in Breast Cancer (A Mini Review). [PDF]

Integr Cancer Ther
Edalat Haghi FA, Koushkie Jahromi M.
europepmc   +1 more source

Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion

Advanced Science, EarlyView.
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li, Yuanxin Li, Asif Rashid, Hong Kee Tan, Shing Chan, Man Yan Hui, Wilson Yau Ki Chan, Kee See Lam, Yinping Liu, Wenwei Tu, Wing Leung   +10 more
wiley   +1 more source

Dysregulated hyaluronan metabolism drives inflammation and angiogenesis in proliferative diabetic retinopathy. [PDF]

Front Immunol
Abu El-Asrar AM, Nawaz MI, Ahmad A, Siddiquei M, Allegaert E, Gikandi PW, De Hertogh G, Opdenakker G.   +7 more
europepmc   +1 more source

CD44 Positive [PDF]

, 2020
openaire   +1 more source